Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Most readers would already know that ISEC Healthcare's (Catalist:40T) stock increased by 9.5% over the past three...
Key Insights Significant control over ISEC Healthcare by public companies implies that the general public has more...
As global markets navigate mixed performances amid economic uncertainties, investors are increasingly scrutinizing opportunities in niche areas like penny stocks. While the term "penny stocks" may seem outdated, these securities continue to offer intriguing prospects for growth, particularly when backed by robust financial health. This article highlights several promising penny stocks that combine affordability with strong fundamentals, potentially offering significant upside in today's...
ISEC Healthcare (Catalist:40T) posted a net profit margin of 16.2%, coming in below last year’s 19.3%, and recorded negative earnings growth compared to an 18.1% compound annual pace over the past five years. The stock is trading at SGD 0.35, below both its estimated fair value of SGD 0.54 and the regional sector’s typical valuation levels. With fundamentals that still compare favorably against peers, investors may be weighing the historical track record against this recent dip in...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.